SEOUL - South Korea declared on Tuesday it is effectively out of danger from Middle East Respiratory Syndrome (MERS), more than two months after the first case was reported and began spreading in hospital settings to kill 36 people.
- French drugmaker Sanofi said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals in the hot area of cancer immunotherapy.
TEL AVIV - Israel’s Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan’s generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential "transformational" acquisitions. | Video
(Reuters Health) - Teens are more likely to use electronic cigarettes if their friends and family view them as cool or acceptable, a new study suggests.
NEW YORK - The U.S. Navy is investigating a complaint that seeks the evacuation of civilian and military lawyers from parts of the U.S. base in Guantanamo Bay, Cuba, following reports of cancer cases among personnel working on the trials of detainees there.
NEW YORK - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
(Reuters Health) - U.S. adults should be screened for depression, according to a proposal from a government-backed panel of medical experts.
(Reuters Health) - Young cancer patients, often left infertile after treatment, may be unaware of ways to preserve their options for having children, a study suggests.
NEW YORK - Despite medical evidence showing the benefits of breastfeeding and how to prevent cot deaths, some doctors are not passing on the information to new mothers in the United States, researchers said on Monday.
(Reuters Health) - Companies fail to report roughly one in 10 serious and unexpected medication side effects to the U.S. Food and Drug Administration (FDA) within a 15-day window specified by federal regulations to protect patient safety, a study finds.